Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 20,578 |
|
|||||
| News | - | ||||||
| Day High | 1.35 | Low High |
|||||
| Day Low | 1.25 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cyclo Therapeutics Inc | CYTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.02 | -1.52% | 1.30 | 17:06:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.35 | 1.25 | 1.35 | 1.30 | 1.32 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 217 | 20,578 | $ 1.28 | $ 26,323 | - | 0.68 - 2.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:59:47 | 8 | $ 1.32 | USD |
Cyclo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 29.55M | 22.73M | - | 1.38M | -15.45M | -0.68 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cyclo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.54 | 1.55 | 1.25 | 1.36 | 37,314 | -0.24 | -15.58% |
| 1 Month | 1.36 | 1.55 | 1.1308 | 1.35 | 41,330 | -0.06 | -4.41% |
| 3 Months | 1.82 | 1.86 | 0.8924 | 1.33 | 54,934 | -0.52 | -28.57% |
| 6 Months | 1.50 | 2.57 | 0.8924 | 1.63 | 70,146 | -0.20 | -13.33% |
| 1 Year | 1.77 | 2.57 | 0.68 | 1.40 | 91,639 | -0.47 | -26.55% |
| 3 Years | 4.19 | 17.75 | 0.68 | 6.66 | 242,965 | -2.89 | -68.97% |
| 5 Years | 4.19 | 17.75 | 0.68 | 6.66 | 242,965 | -2.89 | -68.97% |
Cyclo Therapeutics Description
| Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. |
